LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $830,192 | -20.3% | 13,855 | -4.1% | 0.01% | -20.0% |
| Q2 2023 | $1,041,701 | -1.6% | 14,448 | +0.4% | 0.01% | -9.1% |
| Q1 2023 | $1,058,749 | +146744.5% | 14,393 | +33.4% | 0.01% | 0.0% |
| Q4 2022 | $721 | -99.9% | 10,790 | -6.5% | 0.01% | -31.2% |
| Q3 2022 | $994,000 | -8.6% | 11,539 | -5.3% | 0.02% | -5.9% |
| Q2 2022 | $1,087,000 | -18.5% | 12,187 | +2.9% | 0.02% | -5.6% |
| Q1 2022 | $1,333,000 | -28.4% | 11,848 | -1.7% | 0.02% | -21.7% |
| Q4 2021 | $1,861,000 | +8.3% | 12,050 | -2.3% | 0.02% | +9.5% |
| Q3 2021 | $1,719,000 | +5.6% | 12,337 | -0.6% | 0.02% | +10.5% |
| Q2 2021 | $1,628,000 | -14.0% | 12,409 | -0.0% | 0.02% | -17.4% |
| Q1 2021 | $1,892,000 | +47.4% | 12,411 | -3.9% | 0.02% | +43.8% |
| Q4 2020 | $1,284,000 | -10.3% | 12,912 | -14.0% | 0.02% | -15.8% |
| Q3 2020 | $1,431,000 | +0.9% | 15,016 | +18.4% | 0.02% | -17.4% |
| Q2 2020 | $1,418,000 | +39.6% | 12,681 | -9.2% | 0.02% | +21.1% |
| Q1 2020 | $1,016,000 | -18.9% | 13,972 | +16.3% | 0.02% | 0.0% |
| Q4 2019 | $1,253,000 | -2.7% | 12,013 | -7.2% | 0.02% | -5.0% |
| Q3 2019 | $1,288,000 | -15.2% | 12,940 | -2.7% | 0.02% | -16.7% |
| Q2 2019 | $1,518,000 | -13.0% | 13,301 | -4.2% | 0.02% | -14.3% |
| Q1 2019 | $1,745,000 | -7.5% | 13,882 | -0.2% | 0.03% | -15.2% |
| Q4 2018 | $1,887,000 | -48.2% | 13,908 | +4.7% | 0.03% | -34.0% |
| Q3 2018 | $3,645,000 | +27.8% | 13,279 | -3.5% | 0.05% | +28.2% |
| Q2 2018 | $2,851,000 | +23.6% | 13,760 | -1.5% | 0.04% | +25.8% |
| Q1 2018 | $2,307,000 | +18.1% | 13,971 | -2.1% | 0.03% | +29.2% |
| Q4 2017 | $1,953,000 | -6.1% | 14,266 | -6.6% | 0.02% | -11.1% |
| Q3 2017 | $2,079,000 | +23.2% | 15,273 | +9.9% | 0.03% | +22.7% |
| Q2 2017 | $1,687,000 | +16.0% | 13,899 | +1.2% | 0.02% | +15.8% |
| Q1 2017 | $1,454,000 | +3.1% | 13,740 | -1.0% | 0.02% | 0.0% |
| Q4 2016 | $1,410,000 | -4.4% | 13,872 | -4.0% | 0.02% | -5.0% |
| Q3 2016 | $1,475,000 | -14.6% | 14,457 | -0.2% | 0.02% | -13.0% |
| Q2 2016 | $1,728,000 | +11.3% | 14,488 | -0.1% | 0.02% | +15.0% |
| Q1 2016 | $1,553,000 | -4.6% | 14,505 | -3.4% | 0.02% | 0.0% |
| Q4 2015 | $1,628,000 | +27.3% | 15,020 | +0.6% | 0.02% | +25.0% |
| Q3 2015 | $1,279,000 | -16.7% | 14,936 | -1.9% | 0.02% | -11.1% |
| Q2 2015 | $1,536,000 | +24.2% | 15,225 | -5.1% | 0.02% | +28.6% |
| Q1 2015 | $1,237,000 | +41.7% | 16,046 | -2.2% | 0.01% | +40.0% |
| Q4 2014 | $873,000 | +8.3% | 16,404 | -4.3% | 0.01% | +11.1% |
| Q3 2014 | $806,000 | -38.2% | 17,149 | -18.2% | 0.01% | -30.8% |
| Q2 2014 | $1,305,000 | -6.8% | 20,952 | +0.7% | 0.01% | -7.1% |
| Q1 2014 | $1,400,000 | +23.9% | 20,808 | -3.1% | 0.01% | +27.3% |
| Q4 2013 | $1,130,000 | – | 21,474 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |